Pulse Biosciences, Inc.
PLSE
$17.74
$0.855.03%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -62.45% | -20.01% | -14.86% | -3.43% | -29.75% |
| Total Depreciation and Amortization | -5.59% | -1.67% | -1.32% | -0.99% | -9.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 102.53% | 65.85% | 79.53% | 96.32% | 64.64% |
| Change in Net Operating Assets | 111.74% | 118.83% | 186.57% | -183.67% | 230.36% |
| Cash from Operations | -34.83% | 13.95% | 8.77% | -48.86% | 14.85% |
| Capital Expenditure | -23.26% | -65.22% | -81.25% | 87.18% | -4.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -23.26% | -65.22% | -81.25% | 87.18% | -4.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5,902.61% | 15,169.88% | -99.91% | -37.11% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 5,700.00% | -5,460.00% | -- | -- |
| Cash from Financing | 5,895.27% | 2,780.36% | -101.91% | 170.60% | 4,829.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 747.82% | 731.95% | -286.90% | -34.64% | 24.95% |